EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Steering Committee
Call with Ian on 16th September.
CTF WG1
Call with WG1 on 18th September
CTF WG2
Laszlo is working on the abstract for Congress.
CTF WG3
WG3 is currently following-up with national member associations. A call should be organised before the Steering Committee meeting. @ Joan – could you let us know about your availability.
Accreditation/ECPhA
Shortages
eHealth
President’s guests @ Congress
The President’s guest list (see HERE) has been updated. @ PH do you already want to pick the patient organisation for category 1 or wait until the Board meeting?
EAHP’s policy priorities
Like last September, SK will add the revision of the policy priorities to the Board meeting agenda. Last year the following priorities were agreed for 2018/19:
| 18/09/19 | EMA HCPWP request on AMR | Policy team is working on it together with AMR leads. |
| 20/09/19 | EMA consultation – Draft qualification opinion of Multiple sclerosis clinical outcome assessment (MSCOA) | We won’t comment. |
| 29/09/19 | EMA Consultation: ICH guideline E19 on optimisation of safety data collection | Check relevance with JP. |
| 30/09/19 | EMA Consultation – ICH guideline E8 (R1) on general considerations for clinical studies – Step b | Clinical trial board leads |
| 30/09/19 | EMA public consultation on a draft reflection paper on the qualification of non-genotoxic impurities | We won’t comment. |
| 09/10/19 | EMA consultation – Draft qualification opinion of clinically interpretable treatment effect measures based on recurrent event endpoints that allow for efficient statistical analyses | Check relevance with PP. |
| 31/10/19 | CHMP position statement on Creutzfeldt-Jakob disease and plasma-derived and urine-derived medicinal products | We won’t comment. |
EU tender – Mapping and Assessment of Developments for Sectoral Professions including pharmacists
SK reached out the PGEU. No involvement is planned but Ilaria discussed it with her members this week. She promised to share feedback after the meeting.
SIFO invitation
@PH are you responding to the SIFO invitation yourself, or do you need help?
EHFG
The shortage panel at EHFG contains quite some interesting participants. Timeo Wölken is the new MEP responsible for the HTA file. Kirsten Raudsepp is one of the co-chairs of the EMA/HMA task force on medicines availability.
PPMI tender application
Additional information was requested. PPMI stopped responding.
Next policy call – 9 October?
